TLR-mediated cell signaling by malaria GPIs

Trends in Parasitology

Volumn 23, Issue 12, 2007, Pages 596-604

  Gowda, D Channe ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; MALARIA VACCINE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2;

ADAPTIVE IMMUNITY; DRUG TARGETING; INNATE IMMUNITY; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; MALARIA VACCINES; MYELOID DIFFERENTIATION FACTOR 88; PLASMODIUM FALCIPARUM; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

PLASMODIUM FALCIPARUM;

EID: 36349016500     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.09.003     Document Type: Review

References (73)

1. Snow R.W., et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
2. Sachs J. The economic and social burden of malaria. Nature 415 (2002) 680-685
3. Whitworth J.A., and Hewitt K.A. Effect of malaria on HIV-1 progression and transmission. Lancet 365 (2005) 196-197
4. In: Gilles H.M., and Warrell D.A. (Eds). Bruce-Chwatt's Essential Malariology (1997), Hodder Arnold
5. In: Sherman I.W. (Ed). Malaria - Parasite Biology, Pathogenesis, and Protection (1998), ASM Press
6. Singh B., et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 363 (2004) 1017-1024
7. Baird J.K. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum malaria. Parasitol. Today 11 (1995) 105-111
8. Riley E.M., et al. Regulating immunity to malaria. Parasite Immunol. 28 (2006) 35-49
9. Stevenson M.M., and Riley E.M. Innate immunity to malaria. Nat. Rev. Immunol. 4 (2004) 169-180
10. Lyke K.E., et al. Serum levels of the proinflammatory cytokines interleukin-1β (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect. Immun. 72 (2004) 5630-5637
11. Malaguarnera L., and Musumeci S. The immune response to Plasmodium falciparum malaria. Lancet Infect. Dis. 2 (2002) 472-478
12. Langhorne J., et al. Mouse models of blood stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem. Immunol. 80 (2002) 204-228
13. Muniz-Junqueira M.I., et al. Influence of tumor necrosis factor-α on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro. Cell. Immunol. 208 (2001) 73-79
14. Su Z., and Stevenson M.M. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect. Immun. 68 (2000) 4399-4406
15. Kwiatkowski D. Malarial toxins and the regulation of parasite density. Parasitol. Today 11 (1995) 206-212
16. Clark I.A., et al. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-γ or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J. Immunol. 139 (1987) 3493-3496
17. Schofield L., and Grau G.E. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5 (2005) 722-735
18. Clark I.A., et al. Pathogenesis of malaria and clinically similar conditions. Clin. Microbiol. Rev. 17 (2004) 509-539
19. Mackintosh C.L., et al. Clinical features and pathogenesis of severe malaria. Trends Parasitol. 20 (2004) 597-603
20. Hunt N.H., and Grau G.E. Cytokines: accelerators and brakes in pathogenesis of cerebral malaria. Trends Immunol. 24 (2003) 491-499
21. Artavanis-Tsakonas K., et al. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin. Exp. Immunol. 133 (2003) 145-152
22. Odeh M. The role of tumor necrosis factor-α in the pathogenesis of complicated falciparum malaria. Cytokine 14 (2001) 11-18
23. Clark I.A., et al. The biological basis of malarial disease. Int. J. Parasitol. 27 (1997) 1237-1249
24. Torre D., et al. Role of proinflammatory and anti-inflammatory cytokines in the immune response to Plasmodium falciparum malaria. Lancet Infect. Dis. 2 (2002) 719-720
25. Dodoo D., et al. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J. Infect. Dis. 185 (2002) 971-979
26. Omer F.M., et al. Maintaining the immunological balance in parasitic infections: a role for TGF-β?. Parasitol. Today 16 (2000) 18-23
27. Perkins D.J., et al. Reduced interleukin-12 and transforming growth factor-β1 in severe childhood malaria: relationship of cytokine balance with disease severity. J. Infect. Dis. 182 (2000) 988-992
28. Weatherall D.J., et al. Malaria and the red cell. Hematology Am. Soc. Hematol. Edu. Program (2002) 35-57
29. van der Heyde H.C., et al. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22 (2006) 503-508
30. Schofield L., and Hackett F. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J. Exp. Med. 177 (1993) 145-153
31. Schofield L., et al. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates ICAM-1, VCAM-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via protein tyrosine kinase-dependent signal transduction. J. Immunol. 156 (1996) 1886-1896
32. Tachado S.D., et al. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol. 156 (1996) 1897-1907
33. Schofield L., et al. Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-α-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria. Ann. Trop. Med. Parasitol. 87 (1993) 617-626
34. Naik R.S., et al. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J. Exp. Med. 192 (2000) 1563-1576
35. Boutlis C.S., et al. Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination. Curr. Top. Microbiol. Immunol. 297 (2005) 145-185
36. Schofield L., et al. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418 (2002) 785-789
37. Ferguson M.A.J., et al. The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness. Biochim. Biophys. Acta 1455 (1999) 327-340
38. Ropert C., and Gazzinelli R.T. Signaling of immune system cells by glycosylphosphatidylinositol (GPI) anchor and related structures derived from parasitic protozoa. Curr. Opin. Microbiol. 3 (2000) 395-403
39. Gerold P., et al. Glycosylphosphatidylinositols synthesized by asexual erythrocytic stages of the malarial parasite, Plasmodium falciparum. Candidates for plasmodial glycosylphosphatidylinositol membrane anchor precursors and pathogenicity factors. J. Biol. Chem. 269 (1994) 2597-2606
40. Gerold P., et al. Structural analysis of the glycosylphosphatidylinositol membrane anchors of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. Mol. Biochem. Parasitol. 75 (1996) 131-143
41. Tachado S.D., et al. Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4022-4027
42. Nebl T., et al. Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors. Parasitology 130 (2005) S45-S62
43. Vijaykumar M., et al. Plasmodium falciparum glycosylphosphatidylinositol-induced TNF-α secretion by macrophages is mediated without membrane insertion or endocytosis. J. Biol. Chem. 276 (2001) 6909-6912
44. Akira S. TLR signaling. Curr. Top. Microbiol. Immunol. 311 (2006) 1-16
45. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18 (2006) 3-9
46. Kopp E., and Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15 (2003) 396-401
47. Mukhopadhyay S., et al. The potential for Toll-like receptors to collaborate with other innate immune receptors. Immunology 112 (2004) 521-530
48. Krishnegowda G., et al. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280 (2005) 8606-8616
49. Akira S., and Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85 (2003) 85-95
50. Hoebe K., et al. CD36 is a sensor of diacylglycerides. Nature 433 (2005) 523-527
51. Triantafilou M., et al. Membrane sorting of toll-like receptor TLR2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281 (2006) 31002-31011
52. Patel S.N., et al. Disruption of CD36 impairs cytokine response to Plasmodium falciparum GPI and confer susceptibility to severe and fatal malaria in vivo. J. Immunol. 178 (2007) 3954-3961
53. Lu Z., et al. Disruption of JNK2 decreases the cytokine response to P. falciparum GPI in vitro and confers protection in a cerebral malaria model. J. Immunol. 177 (2006) 6344-6352
54. Zhu J., et al. Induction of proinflammatory responses in macrophages by the GPIs of P. falciparum: the requirement of ERK, p38, JNK and NF-κB pathways for the expression of proinflammatory cytokines and nitric oxide. J. Biol. Chem. 280 (2005) 8617-8627
55. Manning A.M., and Davis R.J. Targeting JNK for therapeutic benefit: from junk to gold?. Nat. Rev. Drug Discov. 2 (2003) 554-565
56. Yang D.D., et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
57. Haruta H., et al. Isolation of a novel interleukin-1-inducible nuclear protein bearing ankyrin-repeat motifs. J. Biol. Chem. 276 (2001) 12485-12488
58. Yamamoto M., et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkBζ. Nature 430 (2004) 218-222
59. Pichyangkul S., et al. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172 (2004) 4926-4933
60. Coban C., et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201 (2005) 19-25
61. Parroche P., et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 1919-1924
62. Mockenhaupt F.P., et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 177-182
63. Mockenhaupt F.P., et al. Common polymorphisms of Toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J. Infect. Dis. 194 (2006) 184-188
64. Khor C.C., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet. 39 (2007) 523-528
65. Adachi K., et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167 (2001) 5928-5934
66. Perry J.A., et al. Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J. Immunol. 174 (2005) 5921-5925
67. Coban C. Pathological role of Toll-like receptor signaling in cerebral malaria. Int. Immunol. 19 (2007) 67-79
68. Togbe D., et al. Murine cerebral malaria development is independent of toll-like receptor signaling. Am. J. Pathol. 170 (2007) 1640-1648
69. Lepenies, B. et al. (2007) Induction of experimental cerebral malaria is independent of TLR2/4/9. Med. Microbiol. Immunol. Epub ahead of print PMID: 17668237 DOI 10.1007/s00430-007-0057-y (http://www.springerlink.com)
70. Franklin B.S., et al. MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Microbes Infect. 9 (2007) 881-890
71. Naik R.S., et al. Developmental stage-specific biosynthesis of glycosylphosphatidylinositol anchors in intraerythrocytic Plasmodium falciparum and its inhibition in a novel manner by mannosamine. J. Biol. Chem. 275 (2000) 24506-24511
72. Sanders P.R., et al. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. J. Biol. Chem. 280 (2005) 40169-40176
73. Naik R.S., et al. Glucosamine inhibits inositol acylation of the glycosylphosphatidylinositol anchors in intraerythrocytic Plasmodium falciparum. J. Biol. Chem. 278 (2003) 2036-2042